| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | Director
3 companies
Doyle William F serves as an Executive Chairman at NVCR and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 13 buys and 51 sells. Those positions are worth an estimated $144K at current prices.
Historically, Doyle William F's trades have earned a middling insider score of 53/100 across 7 rated trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +19.7%.
The biggest single holding is NERV (~$144K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 26,111 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | NVCR Novocure Limited | Executive Chairman | Sell | 71,887 | $12.98 | $932,883.38 | -18.0% | +24.5% | - | |
| May 21, 2024 | ELAN Elanco Animal Health Inc | Director | Buy | 15,000 | $16.98 | $254,700.00 | +24.5% | -11.3% | -24.4% | |
| Mar 8, 2024 | ELAN Elanco Animal Health Inc | Director | Buy | 15,000 | $16.30 | $244,500.00 | +32.4% | +11.1% | -32.3% | |
| Aug 2, 2022 | NVCR Novocure Ltd | Executive Chairman | Sell | 837 | $69.66 | $58,304.58 | -0.2% | +0.7% | -57.1% | |
| Mar 8, 2022 | NVCR Novocure Ltd | Executive Chairman | Sell | 2,385 | $70.10 | $167,188.50 | -0.4% | +13.2% | +6.5% | |
| Aug 2, 2021 | NVCR Novocure Ltd | Executive Chairman | Sell | 995 | $149.38 | $148,631.11 | -0.2% | -28.4% | -53.4% | |
| Apr 13, 2021 | NVCR Novocure Ltd | Executive Chairman | Sell | 95,000 | $199.55 | $18,957,451.92 | -14.6% | -2.9% | -56.0% | |
| Apr 1, 2021 | NVCR Novocure Ltd | Executive Chairman | Sale+OE | 7,928 | $134.12 | $1,063,303.36 | -1.2% | +66.3% | -34.3% | |
| Jul 31, 2020 | NVCR Novocure Ltd | Executive Chairman | Sell | 896 | $76.39 | $68,443.65 | -0.1% | - | - | |
| May 11, 2020 | NVCR Novocure Ltd | Executive Chairman | Sell | 31,332 | $63.73 | $1,996,725.70 | -4.6% | - | - |